The Bird Flu is marching on and becoming an increasing threat as the H5N1 human strain is in Africa causing issues now. Producing enough vaccine fast enough just is not an option if the strain evolves of mutates to flow quickly like Influenza from human to human. One recent article in the Boston Globe accuses Rouche Pharmaceuticals of predatory price strategies for buying up all the Star Anise Fruit Crop a potential component of the TamiFlu vaccine.